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ANATOMIC OUTCOMES AFTER RETINAL DETACHMENT SURGERY IN 
PATIENTS WITH RETINAL DETACHMENT ASSOCIATED WITH 
CHOROIDAL DETACHMENT 
 
JAKE A. BARRETT 
ABSTRACT 
Purpose: To investigate relationships between preoperative and intraoperative 
characteristics with outcome variables in patients suffering from primary 
rhegmatogenous retinal detachment (RRD) or traction retinal detachment (TRD) 
complicated by serous choroidal detachment (CD). Choroidal detachment is a rare 
complication of retinal detachment and the current literature cites generally poor visual 
outcome variables. By investigating a retrospective case series, we hope to elucidate new 
relationships and embolden existing ones so that future physicians can make more 
educated decisions regarding the care for these complicated patients. 
Methods: A retrospective case series analyzed 18 patient’s medical records (18 eyes) 
who had been diagnosed and surgically treated for RRD or TRD associated with a CD at 
the Longwood Medical Eye Center at Beth Israel Deaconess Medical Center. Patients 
with RDCD who had undergone 23-gauge pars plana vitrectomy with silicone oil 
tamponade were selected. Exclusionary criteria included ocular complications such as 
phthisis bulbi and open globe trauma. Patients experienced a variety of surgical 
procedures including by not limited to relaxing retinotomy (n=12 eyes), choroidal 
drainage (n=10 eyes), endoscopy-assisted PPV (n=10 eyes), and ERM peeling (n=8 
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eyes). Primary outcome variables tabulated were primary and final anatomic success, 
defined as successful reattachment of the retina to the underlying choroid, and final visual 
acuity. 
Results: The mean age of the sample group was 69 with 8 patients (44%) diagnosed with 
preoperative hypotony (IOP <= 6 mmHg). A total of 12 patients were pseudophakic 
(67%). With a mean follow-up of 21.6 months, patients exhibited expected visual 
outcomes with 6 patients (33%) improving visual acuity and 7 patients (39%) decreasing 
visual acuity. Final anatomic success was seen in 17 cases (94%). A significant 
correlation was found between decreased number of previous surgeries and better visual 
outcomes (change in BCVA). Another significant relationship correlates choroidal 
drainage with worse visual outcomes (change in BCVA). Finally, patients who received 
ERM peeling had better rates of primary anatomic success. 
Conclusion: The advanced age of the sample lends itself to increased risk for cataracts 
and thus pseudophakia. In addition, high rates of diabetes and macular degeneration 
follow. The pathophysiology of RDCD in relation to the risk factors of hypotony and 
macular holes is possibly based on the Starling forces and favorable fluid transudation 
into the suprachoroidal space. Although the outcomes of this study were similar to 
previous literature, the visual outcomes are still poor at best. Reducing the number of 
previous, invasive, ocular surgeries was seen to be correlated with better visual outcomes. 
In addition, performing ERM peels is seen to be correlated with improved rates of 
primary anatomic success. More research is required on the etiology of the disease 
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process and a case-controlled longitudinal study may be helpful in determining more 
relationships with outcome variables.  
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INTRODUCTION 
 
 The human eye is the major visuospatial organ at the anterior face of the skull. 
The eye is a fluid-filled sac that refracts light through a convex cornea and intraocular 
lens to focus objects on the retina (Sutter et al., 2000). The anatomy of the eye can be 
split into anterior and posterior segments, separated by the lens. The anterior segment is 
Figure 1: Schematic representation of the human eye. Light enters through the cornea 
where it is refracted by the lens and focused on the retina. The anterior segment is filled 
with aqueous humor, while the posterior segment is filled with vitreous humor. Image 
from (Kolb, 2005). 
 2 
again split into the anterior chamber (AC; anterior to the iris) and the posterior chamber 
(PC; posterior to the iris). Anterior segment spaces are filled with extracellular aqueous 
humor while posterior segment spaces are filled with a more viscous, extracellular 
vitreous humor. Notable structures within the anterior segment include the cornea, lens, 
iris, ciliary body, and anterior sclera. Major structures of the posterior segment include 
the retina, vitreous chamber, choroid, and optic nerve (Kolb, 2005). 
Retina/Choroid  
 The retina is the light-sensitive, neuronal cell layer at the posterior aspect of the 
vitreous chamber (Kolb, 2012). It is located immediately proximal to the vitreous humor 
and distal to the choroid. The retina is composed of several layers of cells including 
neurons, photoreceptors, and glial cells. From the vitreous boundary these layers are: the 
Figure 2: Schematic representation and histological preparation of a mammalian retina. 
Light enters through the cornea and travels through the vitreous before contacting the 
ganglion cell layer at the distal aspect of the retina. Figure taken from (Duong et al., 
2008). 
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ganglion cell layer, inner plexiform layer, inner nuclear layer, outer plexiform layer, outer 
nuclear layer, photoreceptor segment, and retinal pigment epithelium (Duong et al., 
2008). Light is absorbed by vitamin A in the rod and cone cells of the photoreceptor 
segment where it is converted into an electrochemical potential and sent to the visual 
cortex for analysis (Kolb, 2012). Rod cells analyze black and white light while cone cells 
analyze color light. The retinal pigment epithelium (RPE) is considered the posterior 
boundary of the retina. These cells cycle the vitamin A necessary for vision and maintain 
a proper extracellular milieu for the retina (Strauss, 2005). 
 The macula is the most light sensitive region at the center of the retina that makes 
up the majority of stereoscopic vision. This region is responsible for central vision and, 
when focused on an object, aligns perfectly with the center of the lens and the object in 
question. At the center of the macula is the fovea, which is the spot with the highest 
concentration of photoreceptors; this area is composed of solely cone photoreceptors. 
These structures provide the highest visual acuity in mammalian eyes (Provis et al., 
2005). Few retinal vessels exist towards the center of the macula as to avoid any 
obstruction of passing light. This region is significant for pathological concerns including 
cystoid macular edema (CME), proliferative and nonproliferative diabetic retinopathy 
(PDR/nPDR), wet and dry age-related macular degeneration (wet AMD/dry AMD), and 
macular holes (Amsler, 1953). 
 The choroid is a spongy, porous tissue that is immediately subjacent to the RPE. It 
is considered one of the most highly vascularized tissues in the human body due to the 
choriocapillaris system. While the retinal vessels supply the inner layers of the retina, the 
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choroid supplies the outer retina, including the photoreceptor segment, with oxygen-rich 
blood (Funk, 1997). Given diffusion distance, the choroid is unable to adequately nourish 
the inner retina and the retinal vessels are unable to nourish the outer layers. There exists 
a plethora of regulatory mechanisms to control this blood flow. One such mechanism is 
that of an intrinsic, non-vascular smooth muscle system that harbors the ability to 
manipulate the thickness of the choroid and alter perfusion rates. In addition, this 
dynamic ability to change its width will move the retina forward and backward, 
ultimately aiding in focusing light onto the retina; somewhat like the process of 
accomodation (Nickla & Wallman, 2010). Important to note is the presence of a 
membrane known as Bruch’s membrane at the distal aspect of the choroid. Bruch’s 
membrane serves as the chief extracellular matrix binding the choroid to the overlying 
RPE and serving as a region of oxygen transfer, nutrient storage, and waste exchange 
between the outer retina and systemic circulation (Booji et al., 2010).  
Detachments 
 There exists a special, potential space between the retina and the choroid that is an 
anatomically closed region that may become a pathological lumen. The RPE and Bruch’s 
membrane of the distal choroid are usually in apposition with one another. Dysfunction 
can result in fluid accumulation or tractional seperation; this leads to detachment of the 
retina from the underlying choroid. Three types of retinal detachments are possible: 
rhegmatogenous retinal detachment (RRD) from a retinal break allowing accumulation of 
vitreous in the potential space, tractional retinal detachment (TRD) from membranes and 
scar tissue causing traction on the retina pulling it away from the choroid, and 
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exudative/serous retinal detachment from inbalanced Starling forces (pressure gradients 
governing fluid movement across membranes) in the RPE causing a transudation of fluid 
into the potential space (Jalali, 2003). Retinal detachment causes ischemia in the 
photoreceptor segment that leads to rapid and progressive atrophy of the photoreceptor 
cells causing severe vision loss . This is widely considered to be an ophthalmic 
emergency that may require prompt surgical intervention depending on the severity of the 
detachment (Feltgen & Walter, 2014). The American Academy of Ophthalmology and 
Figure 3: Schematic of a healthy human eye with labeled structures (A) and a retinal 
detachment showing both RRD with a retinal tear causing accumulation of subretinal 
fluid and a TRD with vitreous traction causing a peeling effect on the retina (B). Figure 
taken from (Feltgen & Walter, 2014). 
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previous studies states that the world-wide incidence of RRD is roughly 1 in 10,000 
people. (Haimann et al., 1982).  
 Detachment of the choroid from the underlying sclera involves another potential 
space, known as the suprachoroidal space (SCS), and is due to transudation of fluid from 
the choroidal vessels into the SCS. Serous choroidal detachments (SCD) form when the 
eye experiences a low intraocular pressure (IOP), termed hypotony, and often accompany 
inflammation. Hemorrhagic choroidal detachments (HCD) occur when a small vessel 
hemorrhages within the choroid, which is usually a result of intraocular surgery (Bellows 
et al., 1981). Most idiopathic choroidal detachments resolve on their own and do not 
require surgical intervention (Obuchowska & Mariak, 2005). 
 A less studied ocular event in which a primary RRD is complicated by a 
secondary SCD can have devastating implications to the visual acuity of the patient. The 
rhegmatogenous retinal detachment/choroidal detachment (RDCD) was first described by 
Gottlieb in 1972. He proposed a severe form of RRD that is superimposed by a SCD 
involving marked inflammation and hypotony, defined as an IOP of <6 mmHg, (Gottlieb, 
1972). Historically, this form of detachment has profoundly decreased rates of 
improvement and surgical success (Adelman et al., 2014). Thus, RDCD is known as a 
serious complication of detachment that may lead to severe vision loss. Roughly 2-4.5% 
of retinal detachments are believed to present as RDCD (Seelenfreund 1974).  
Pathogenesis 
 The pathogenesis of a RRD involves a process of fluid accumulation in the 
subretinal space. There are three causal indicators of the pathogenesis of RRD. Posterior 
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vitreous detachment (PVD) is a natural process of aging in which the posterior hyaloid 
membrane of the vitreous chamber seperates from the retina and the gel-like vitreous 
loses viscosity over time. An idiopathic macular hole (IMH) is a retinal tear located 
within the macula that allows the less viscous fluid to settle underneath the retina. 
Vitreomacular traction (VMT), when the vitreous creates a shearing force on the macula, 
is believed to play a significant role in the detachment of the retina. After fluid 
accumulation, VMT peels the retina away from the choroid causing loss of vision (Steel 
et al., 2013). Severe vision loss is usually accompanied by photoreceptor apoptosis. Since 
the photoreceptor segment of the retina is nourished by the choriocapillaris system, 
increased distance from these vessels causes ischemic atrophy of the rods and cones 
(Arroyo et al., 2005). A pathway mediated by fibroblast growth factor receptor 1 
(FGFR1) and activator protein 1 (AP-1) is thought to initate the molecular changes in the 
RPE and retina that lead to progressive, apoptotic death (Geller et al., 2001).  
 Research is sparse on the pathogenesis of combined RDCD. In 1971, Gottlieb 
described the inflammation and hypotony that are associated with this detachment. 
Metabolomic studies of the vitreous during RDCD events has revealed a myriad of 
inflammatory factors that are causal to this heightened state of inflammation (Yu et al., 
2015). In addition, inflammatory markers were seen in the fluid drained from the SCS, 
indicating obvious inflammatory etiology (Dai et al., 2015). Hypotony is an important 
indicator and pathogenic component of RDCD. Hypotony in the eye and inflammation of 
the choriocapillaris system may cause an imbalance in the Starling forces around the 
vessels. This causes fluid transudation out of the vessels into an area of low pressure, 
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hence the serous nature of the SCD (Rahman & Harris, 1992). As this fluid accumulates 
in the SCS, the choroid burgeons and sperates from the sclera causing detachment. 
Complications 
 Proliferative Vitreoretinopathy (PVR) is a common complication of RRD and 
oft cited as a primary reason for surgical failure (Pastor, 1998). PVR is the growth of 
scar tissue and cellular membranes on the superficial interface between the retina 
and vitreous that results in the generation of traction. The process of retinal 
detachment causes a change in glial cell morphology and proliferation within the 
retina that ultimately begins the process of scar formation (Fisher et al., 1991).  
The Müller cells are the resident glial cell of the retina and have been implicated in 
the pathogenesis of PVR. An injury-response system causes glial cells to proliferate 
Figure 4: Fundus Photograph of PVR depicting areas of white scar tissue accumulation 
with star folds and tractional rippling. This is a right eye, as seen by the optic cup and 
retinal vessels appearing at image right. Figure taken from (Sadaka et al., 2012). 
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and dedifferentiate to form an external membrane of scar tissue (Lewis et al., 2010). 
PVR is estimated to occur in roughly 8-10% of RRD cases (Nagasaki et al., 1998). 
Diagnosis 
 Diagnosis of RDCD follows similar criteria to a normal RRD. Risk factors were 
tabulated in a 2016 study by Gu et al. Pseudophakia (intraocular lens placement post 
cataract surgery) was significantly higher in RDCD patients. Hypotony was significantly 
more prevalent than RRD patients. Best corrected visual acuity (BCVA) was worse in 
RDCD patients. The extent of myopia was significantly more severe than RRD. Larger 
extent of retinal detachment (defined by clock hours of detachment) is seen in RDCD. 
Many RDCD patients exhibit multiple retinal breaks and significantly more macular 
holes (Gu et al., 2016). Besides risk factors, three main diagnostic imaging modalities are 
employed. 
Fundus Examination 
 Examination of the fundus (back of the eye) is performed on dilated eyes and uses 
Figure 5:Fundus examination showing peripheral openings. Visible scleral tissue 
indicates bilateral choroidal detachments in the periphery. This detachment is situated 
nasally. OD = oculus dexter (right eye)/OS = oculus sinister (left eye). Figure taken from 
(Malagola et al., 2013). 
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indirect ophthalmoscopy or the slit lamp to view the interior surface at the posterior 
aspect of the vitreous chamber. Clinical manifestations for anomalous fundus 
examination include but are not limited to: retinal folds indicating a retinal detachment, 
PVR scarring indicating complicated detachment, and open regions revealing scleral 
tissue indicating choroidal detachment. 
Optical Coherence Tomography 
 Optical coherence tomography (OCT) uses light wave interferometry to measure 
scatter and deliver clear cross-sectional images of biological structures (Huang et al., 
1991). With the noninvasive ability to relay information concerning macular thickness, 
separation distance, fluid accumulation, and macular involvement, the OCT is a powerful 
tool for diagnostics. However, it is not the primary means of diagnosis for RDCD, but 
more of a prognostic tool to determine outcomes and severity of detachment. The use of 
Figure 6: SD-OCT image using enhanced depth imaging showing central serous 
chorioretinopathy. Prevalent subretinal fluid is visible between the RPE and 
photoreceptor segment. The arrow heads depict the proximal border of the choroid, 
which is markedly thickened in this image. Image taken from (Chhablani & Barteselli, 
2015). 
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spectral domain OCT (SD-OCT) is increasing in popularity as it allows for higher 
resolution and enhanced depth of imaging allowing more clear views of the choroid and 
underlying structures. 
B-Scan Ultrasonography 
 Ultrasonography utilizes the reflection of sound waves to visualize internal 
structures. Sound waves are reflected off tissues with differing densities and collected by 
a receiver. The receiver converts that signal into a digital image depicting depth and 
structure depending on the change in density between different tissues (Abu-Zidan et al., 
2011). A B-scan is an ultrasound of the inner eye performed on a closed eyelid that 
depicts internal structures. In some cases, the vitreous may become hazy or a cataract can 
Figure 7: B-scan of the left eye depicting HCD in four quadrants. The arrows are 
pointing towards the hemorrhagic choroidal detachments. Image taken from (Senthil et 
al., 2015). 
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obstruct the view rendering ophthalmoscopy insufficient. An ultrasound can be used to 
diagnose different detachments including RRD and SCD. 
Treatment 
 Treatment for RDCD involves treating the underlying causes of the RRD and the 
SCD in conjunction. Since this type of detachment is very serious and involves a poor 
prognosis, there is a more standardized set of procedures for such a complicated 
detachment. While some less extensive RRDs may be dealt with in an outpatient setting 
using cryotherapy or photocoagulation and many SCDs warrant a “wait and see”-type 
approach, combined RDCD will almost always require surgical intervention to maintain 
visual acuity for the patient.  
 The status of the macula can be an indicator of the prognosis. If the macula is not 
involved in the detachment, it is referred to as a “mac-on” detachment. In this 
circumstance, surgical outcomes are the best and prompt surgical intervention is vital to 
maintaining the highest possible visual acuity (Mahmoudi & Almony 2016). On the other 
hand, when the macula is involved, it is known as a mac-off detachment. Surgery is 
usually still inevitable but waiting up to a week will not affect the already lower visual 
and anatomical outcomes (Mowatt et al., 2015). 
 Surgical procedures are almost always necessary to ensure the cessation of vision 
loss in RDCD patients. Commonly, surgeons will apply scleral buckle (SB) and/or pars 
plana vitrectomy (PPV) to deal with most of the detachment. In addition, intraocular 
tamponade, relaxing retinotomy, and choroidal drainage are widely performed to improve 
anatomic success. In conjunction, these procedures offer a viable chance for increased 
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visual outcomes for patients with RDCD. Below is a more detailed description of each 
technique. 
Pars Plana Vitrectomy 
 PPV is the most widely performed retinal, ophthalmic procedure for repair of 
detachments. The modern form of this surgical technique was developed by Dr. Robert 
Machemer in 1971. The PPV involves a multi-port system that allows the simultaneous 
addition of a vitreous cutter, light pipe, and infusion system. In this way, trimming of the 
vitreous (vitrectomy) using the vitreous cutter is aided by the visibility offered from the 
light pipe. Vitreous removal reduces traction allowing for repair of retinal detachments 
(Machemer et al., 1971). The use of an intraocular tamponade of an expansive gas is 
important in making sure that the retinal breaks are sealed and pressed into apposition 
with the choroid, allowing the natural process of healing to begin. The simplest of these 
procedures is a standard fluid-air exchange, in which normal, ambient air is placed within 
the vitreous cavity; however, many forms of intraocular tamponade have since been 
developed (Machemer 1995). One negative side effect of the PPV is that its invasive 
nature introduces oxygen into the vitreous. This leads to oxidative stress on the lens, 
which quickens the formation of cataracts. Indeed, phacoemulsification (removal of 
cataract) is the most common postoperative surgery necessary for phakic patients (van 
der Vaart 2015). Patients that are pseudophakic have already undergone 
phacoemulsification and placement of a posterior chamber intraocular lens (PCIOL); 
these patients are most aptly indicated for PPV. 
 14 
 
Intraocular Tamponade 
 Intraocular tamponade is defined as the use of a tampon (plug or tent) to plug a 
wound and arrest fluid leakage or hemorrhage. In this case, a gas or liquid substrate is 
inserted into the eye to accomplish the tamponade (Vaziri et al., 2016). In recent decades, 
the series of silicone study reports by the silicone study group have reviewed tamponades 
of differing molecular structures in comparison to silicone oil (SO). In most occasions, 
silicone oil out performs almost all other gas tamponades in outcome variables (Silicone 
Study Report 1-7). However, there are some indications that exist for continued usage of 
perfluoropropane, sulfur hexafluoride, and others.  
Figure 8:A three-port pars plana vitrectomy visualized from the external eye (a) and the 
intraocular eye (b). The three-port system allows simultaneous use of the vitreous cutter, 
light pipe, and infusion system. As the vitreous is trimmed, a tamponade of gas is injected 
through the infusion cannula, sealing breaks and pressing the retina flat against the 
choroid. Image labeled for reuse from Wikimedia. 
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 The goal of an intraocular tamponade is to close the retinal breaks and keep the 
retina against the choroid. Different tamponades provide variability in expansivity, 
duration, and surface tension. Increasing surface tension allows for a better seal of retinal 
breaks, which improves the chance of repair (de Juan et al., 1985). Intraocular 
tamponades are intrinsically temporary, either being absorbed and replaced with vitreous 
or forcibly removed by aspiration such as with SO (Cockerham et al., 1970). Thus, 
differences in tamponade duration and the gas expansion lead to different results that are 
indicated depending on patient characteristics and the extent of the detachment. Silicone 
oil has no expansivity and its duration is theoretically limitless, which is an improvement 
from other gas-type tamponades. However, SO does come with its own set of drawbacks. 
Owing to its unlimited time course, the silicone oil must be aspirated during a second 
PPV, which is adding to the number of invasive surgical procedures. In addition, silicone 
oil can become emulsified and enter the AC, which causes glaucoma and may lead to 
vision loss. Left unchecked and unremoved, silicone oil can have detrimental effects to 
the patient (Light, 2006). Below is a table summarizing many of the characteristics of 
different gas and oil tamponades for use during PPV for repair of retinal breaks 
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Table 1: Intraocular Tamponade; Types and Variables. Shows the types of 
tamponade in the left column and different variables in the further columns. Four 
commonly used gases and silicone oil are displayed. Note the lower surface tension for 
SO but the unlimited duration and lack of expansion. PDMS – polydimethylsiloxane. 
Table adapted from (Vaziri et al., 2016). 
 
Chemical 
Formula 
Gas 
Expansion 
Expansion 
Time 
Tamponade 
Duration 
Surface 
Tension 
(mN)/m 
Air N/A N/A N/A 5 – 7 days 70 
Sulfur 
Hexafluoride 
SF6 2 1 – 2 days 14 days 70 
Perfluoroethane C2F6 3 1 – 3 days 4 – 5 weeks 70 
Perfluoropropane C3F8 4 3 – 4 days 8 weeks 70 
Silicone Oil PDMS N/A N/A Unlimited 35 
 
Relaxing Retinotomy 
 The relaxing retinotomy is a procedure that shortens portions of the peripheral 
retina to reduce traction and comfortably reduce the amount of PVR present (Machemer 
1981). The retinotomy was first developed by Machemer 1981. Since then, it has been 
indicated in complicated cases of retinal detachments with PVR or risk of developing 
PVR. Retinotomy can also aid in flattening the retina when intraocular tamponade is 
insufficient in rendering the retina flat against the choroid. Vitreous cutters and right-
angle scissors are employed in reducing areas of the wrinkled retina that are stricken by 
PVR and scarification (Machemer 1981). 
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Choroidal Drainage 
 Choroidal drainage procedures were popularized in the 2000’s by Dr. WuDunn. 
These drainage procedures were indicated for postoperative choroidal effusions related to 
glaucoma surgeries such as trabeculotomy (WuDunn et al., 2005). RDCD is associated 
with marked hypotony and inflammation that results in effusion of fluid into the SCS. 
Thus, it makes logical sense that a choroidal drainage would be helpful in achieving 
anatomical success for the RDCD. SCD and HCD can both benefit from the drainage of 
fluid from the SCS by removing inflammatory mediators and bringing the choroid into 
apposition with the sclera (Verma et al., 2004). 
Scleral Buckle 
 The modern SB was popularized in 1957 by Dr. Schepens et al. The scleral buckle 
was designed as a method of closing retinal breaks by the placement of concentric 
silicone bands around the sclera of the eye. These bands are tightened to form a minor 
indentation around the eye, which collapses the vitreous cavity closing breaks and 
cinching the retina against the RPE (Schepens et al., 1975). By closing the distance 
between the RPE and the detached retina, the natural repair process can begin to reattach 
the retina to improve vision. Scleral buckles have a success rate higher than pneumatic 
retinopexy but slightly lower than pars plana vitrectomy at roughly 80-90% (Haritoglou 
et al., 2010). SB is indicated for RRDs in younger, phakic patients due to its less invasive 
nature compared to PPV. 
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Visual Acuity 
 Visual acuity (VA) is the ability to accurately distinguish visual stimuli. There are 
several factors that work in conjunction to determine the VA of a patient. Haziness of the 
vitreous and aqueous humors can alter the ability of light to penetrate to the retina. In 
addition, afferent neuronal pathways from optic nerve to lateral geniculate nucleus and 
superior colliculus must be intact to maintain proper visual functionality. Also, the ability 
for the eye to correctly focus light on the fovea is of the utmost importance in receiving 
sharp, stereoscopic vision. Finally, any ocular abnormalities, such as a detachment or 
hemorrhage, can alter visual acuity. Conducting efficient and accurate tests of visual 
acuity can reveal an enormous amount of physiological and pathological information 
about the status of the eye; analogous to blood pressure for systemic health. Measurement 
of visual acuity uses the Snellen chart, developed by Dr. Snellen in 1862. The Snellen 
chart uses several lines filled with characters of differing sizes known as optotypes. With 
Figure 9: Schematic representation of a scleral buckle placement around the eye. Note 
the indentation formed in the retinal and choroidal layers. These indentations travel 
concentrically around the circumference of the globe. Image labeled for reuse from 
Wikimedia. 
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a standard value set at 20/20 (6/6 in metric), the human eye at this performance level 
should be able to distinguish the optotypes from 20 feet away (or 6 meters).  
Specific Aims and Objectives 
 The goal of this study is to investigate differing outcome variables of patients that 
present with RDCD. Looking at preoperative factors such as diabetes, hypotony, and 
previous surgeries and comparing these groups to a control group of patients that present 
with an RRD (but no SCD). In addition, intraoperative factors may also affect visual 
outcomes such as differing treatment procedures and average follow-up time. This study 
aims to delineate specifics that may aid physicians in making more educated treatment 
decisions to maximize outcomes with their patients who present with RDCD. 
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METHODS 
Inclusion Criteria 
 This nonrandomized, consecutive case series was conducted with data from a 
single vitreoretinal surgeon at Beth Israel Deaconess Medical Center. Surgical dates for 
cases ranged from June 2006 to October 2017. All case data was located using billing 
data, surgical data, online medical records, and paper charts. Initially, patients with 
retinal detachment who underwent 23-gauge PPV with SO tamponade were identified 
(n=230). Combined RD and CD cases were selected from this list through comprehensive 
review of medical records. At first, only RRD cases were included (n=12). However, 
later it was broadened to include TRD patients as well (n=6). Patients with open globe 
trauma or preoperative phthisis bulbi were excluded as well as those who did not receive 
intraocular tamponade of SO. 18 patients (n=18 eyes) were included in this study. 
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Measurements of Visual Acuity 
 Visual acuity is commonly measured in the Snellen scale using maximum feet for 
discernible optotypes. However, conversion to a more numeric and logarithmic scale is 
beneficial for statistical comparison. This study converted all Snellen visual acuity 
measurements for BCVA to the logarithm of the minimum angle of resolution 
(LogMAR). Dr. Holladay developed this conversion in 1997 to better estimate and 
compare outcomes of BCVA with increased accuracy. The equation for conversion is as 
follows (Holladay, 1997): 
LogMAR = (-)Log(Decimal Acuity) 
Below is the conversion chart that was used for this study. 
Figure 10: This inclusion flow chart depicts the process of elimination leading to a final 
sample size of n=18. The inclusion of TRD cases is beneficial for accurate outcomes for 
combined RD & CD patients. 
Total RRD with 23g PPV 
and SO tamponade 
(n=230) 
RRDCD 
(n=12) 
218 cases removed when not 
being diagnosed with 
simultaneous RRDCD 
Sample of RDCD with 
some TRDCD cases 
(n=18) 
Broadened search and included 
cases with TRD 
(n=6) 
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Table 2: LogMAR Conversion Chart. Shows the common LogMAR values ascribed as 
a conversion to standard Snellen values determined in clinic. For measuring BCVA. 
Developed with information from (Holladay, 1997). 
Snellen LogMAR 
20/20 0 
20/25 0.1 
20/30 0.18 
20/40 0.3 
20/50 0.4 
20/60 0.48 
20/70 0.54 
20/80 0.6 
20/100 0.7 
20/150 0.88 
20/200 1 
20/400 1.3 
Count Fingers (CF) 1.85 
Hand Motions (HM) 2.3 
Light Perception (LP 2.6 
No Light Perception (NLP) 3 
 
Diagnostic Procedures 
 Patients were seen in the Beth Israel Deaconess Medical Center Department of 
Ophthalmology for a formal work-up and diagnosis prior to deciding on a treatment plan. 
Patients are dilated oculus uterque (OU, both eyes) and administered a visual 
examination using standard Snellen format. In addition, a pressure reading is obtained, 
and an SD-OCT image taken for retinal diagnostic purposes. Finally, a complete 
ophthalmoscope examination is performed, OU, to explore the fundus of the eye in 
search of any posterior pole abnormalities. If the view of the retina is obstructed for any 
reason and ophthalmoscopic exploration is deemed insufficient, a B-scan ultrasound was 
performed. Once the diagnosis of retinal detachment with secondary choroidal 
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detachment was determined, the patient was informed of this disease. Prognostic 
indicators, recurrence, PVR, treatment options, and recovery times were all discussed 
with the patient so that they were well informed of their situation. PPV with SO 
tamponade is the baseline procedure for all cases in this study (n=18), with added 
procedures as considered necessary by the attending vitreoretinal surgeon. 
 If the patient decided on a treatment plan consisting of PPV and SO tamponade, 
they were informed of the inherent risks with ocular surgery. There is a risk of 1 in 1,000 
to develop a hemorrhage or infection that may lead to complete loss of vision. All 
vitreoretinal procedures have the chance of developing retinal tears and detachment in 
approximately 1 in 100 patients. These tears are typically corrected intraoperatively but 
some may require additional surgery for repair. Vitrectomy is associated with increased 
risk of developing cataract in patients over 50 years of age due to the oxidation 
introduced in the vitreous cavity. After full disclosure of treatment options, risks, and 
possible outcomes, the patient signed consent forms and scheduled a surgery on the next 
available date. 
Surgical Procedures 
 All patients (n=18 eyes) underwent complex, three-port, 23g PPV. The patient 
was brought into the operating room where electrocardiogram, oxygen sensors, and blood 
pressure monitors were placed and monitored for the duration of the case. The operative 
eye was draped to form a sterile field and a wire lid speculum was used to peel the lids 
apart. A retrobulbar infusion of a 50:50 combination of 2% lidocaine and 0.75% 
bupivacaine with added epinephrine and hyaluronidase was administered to support 
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anesthesia and akinesia. Sclerotomies were performed posterior to the limbus in the 
superonasal, superotemporal, and inferotemporal regions. A 4 mm infusion cannula was 
inserted into the infertemporal sclerotomy and the tip was inspected to be safely within 
the vitreous cavity (n=18 eyes).  
After the initial three-port sclerotomies were formed, two additional sclerotomies 
were made with the MVR blade superotemporally and inferonasally, posterior to the 
limbus. A choroidal drainage was performed through these additional sclerotomies until 
the retina and choroid were seen to subtract posteriorly (n=10). A viscoelastic gel was 
inserted into the AC and a pars plana lensectomy was performed using the fragmatome 
and the vitreous cutter to remove capsular debris (n=2). The vitreous was trimmed to the 
vitreous base using the vitreous cutter and, if necessary, a membrane peel was performed 
using forceps (n=9 eyes). Ciliary body membrane was peeled with endoscopic assistance 
using the MVR blade, bent retinal pick, vitreous cutters, and forceps 360-degrees around 
the ciliary processes (n=3 eyes). Preparations were made for relaxing retinectomy with 
intraocular endodiathermy (n=12 eyes). The vitreous cutter was used to perform a 
retinectomy and scar tissue was excised to eliminate remaining traction and prevent 
recurrence and proliferative vitreoretinopathy (n=12 eyes). Perfluoro-N-octane was 
injected to flatten the retina and choroid into apposition with the sclera (n=9 eyes) and a 
standard fluid air exchange was performed (n=9 eyes). Barrier endolaser 
photocoagulation was applied concentrically on the edges of the retinotomy site and 
retinal breaks (n=15). Silicone oil tamponade (5000 or 1000 centistoke) was used for all 
cases (n=18 eyes). Intravitreal and sub-Tenon’s triamcinolone injection was administered 
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to prevent postoperative inflammation (n=18). Endoscopic vitrectomy was performed in 
10 patients (n=10 eyes) to improve visual clarity and aid in vitreous base dissection as 
well as fundus exploration for membrane peeling.  The sclerotomies were closed and 
inspected to be water-tight. The pressure in the eye after SO tamponade was left normal 
at the conclusion of the case. A subconjunctival injection of cefazolin and dexamethasone 
was administered. One drop of 1% atropine was given in the operative eye before a soft 
eye pad and hard eye shield were secured to the face. 
Two patients (n=2 eyes) received 41-band scleral buckle placement. A 360-degree 
peritomy was performed and all tenons separated from the sclera with curved scissors. 
Muscles were looped with 2-0 silk suture. The 41-band was wrapped around the eye 
attached at the ends by a 70 sleeve. The band was sutured into place using 5-0 nylon 
suture. The buckle is then tightened to produce scleral indentation.  
One patient (n=1 eye) received combined PPV and phacoemulsification with 
PCIOL placement. An incision was made on the treatment eye with a #15 blade and 1% 
xylocaine was instilled into the AC. A corneal tunnel was made with the keratome. 
Meanwhile, a circular capsulorrhexis was made with the cystitome and forceps for 
hydrodissection and hydrodelineation. The phacoemulsification tip was placed in the AC 
and nuclear fragments were emulsified and aspirated using a vacuum. Hyaluronic acid 
was injected into the capsular bag and a lens cartridge inserted into the eye where the lens 
was rotated into position. The sodium hyaluronate was aspirated and the cornea sealed. 
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Statistical Analysis 
Statistical analysis was performed using Microsoft Excel 2016. Logistic analysis 
was at the bivariate level, comparing preoperative factors, intraoperative factors, and 
outcome variables for significance. Parametric analysis included Student’s t-test for two-
tailed, between groups analysis. P values were considered significant at the 0.05 level for 
a confidence interval of 95%. This study was approved by the Beth Israel Deaconess 
(BIDMC) Institutional Review Board (IRB)/Committee on Clinical Investigations (CCI) 
and all procedures followed Declaration of Helsinki guidelines. 
 Outcome variables were the main source of statistical analysis. Three variables 
were collected and used to determine surgical and physiological outcomes. Primary 
anatomic success was determined by the accurate reattachment of the retina to the 
choroid with subsequent recurrence of detachment. BCVA was collected preoperatively 
and postoperatively. Final BCVA was measured on the most recent recorded follow-up 
visit and used as a measure of outcome. The change in BCVA was calculated from 
preoperative BCVA and final measured BCVA as another determinant of outcome. 
A control group was developed using control matching. Controls were considered 
effective if they were able to match a set of criteria within reasonable limits. Patients with 
a complicated retinal detachment that received PPV and silicone oil tamponade were 
selected for matching. Criteria included: status of the macula, number of previous 
vitrectomies, presence of PVR, age, and phakic status. The matched control group 
consisted of 18 patients and was used for statistical comparison with the sample group. 
Statistics were performed on the overall outcome variables for a between groups analysis 
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of anatomic success, final BCVA, and change in BCVA for the RDCD group compared 
to the RRD control group.  
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RESULTS 
Preoperative Factors 
 A total of 18 patients were included in the retrospective, non-consecutive case 
series (n=18 eyes). Preoperative characteristics are listed in Table 3. The sample age 
ranged from 37-86 years old with a mean of 69. Sex distribution was skewed female with 
11 males (61%) and 7 females (39%). Preoperative BCVA was normally distributed 
around a mean of 1.79 (logMAR). Twelve patients were pseudophakic (67%) with 4 
patients phakic (22%) and 2 aphakic (11%). Eight patients were diagnosed diabetic 
(44%), with 4 patients diagnosed with nPDR (22%) and 2 patients with PDR (11%). One 
patient had wet AMD (6%) and one other patient had dry AMD (6%). There were 10 
patients (56%) that had experienced a retinal detachment in the treatment eye prior to the 
choroidal event and were thus recurrent detachments. Eight patients were diagnosed with 
proliferative vitreoretinopathy (PVR) prior to surgery. Eight patients were diagnosed with 
preoperative hypotony (44%), which was defined as an IOP <= 6 mmHg. 
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Table 3: Preoperative Characteristics. Shows preoperative characteristics for all 
patients prior to surgical intervention. Factors are separated into categories that represent 
clinical themes. All values represented as integers with percent sample in parentheses. All 
eyes n=18. 
Preoperative Characteristics 
  All Eyes (n=18) 
Age   
Mean 69.11 
Median 70 
Range 37-86 
Sex   
Male 11 (61%) 
Female 7 (39%) 
Best Corrected Visual Acuity (logMAR)   
<1.5 5 (28%) 
1.5-2.0 6 (33%) 
>2.0 7 (39%) 
Lens Status   
Phakic 4 (22%) 
Pseudophakic 12 (67%) 
Aphakic 2 (11%) 
Preliminary Factors   
Diabetic 8 (44%) 
non-Proliferative Diabetic Retinopathy 4 (22%) 
Proliferative Diabetic Retinopathy 3 (17%) 
Dry Age-related Macular Degeneration 1 (6%) 
Wet Age-related Macular Degeneration 1 (6%) 
Uveitis 1 (6%) 
Glaucoma 4 (22%) 
Hypertension 5 (28%) 
Recurrent Retinal Detachment 10 (56%) 
Proliferative Vitreoretinopathy 8 (44%) 
Hypotony (IOP <= 6mmHg 8 (44%) 
 
Detachment Characteristics 
 Detachment characteristics and past surgical data are represented in Table 4. Eight 
patients were macula off detachments (44%) and 10 patients were macula on detachments 
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(56%). Twelve patients had a retinal detachment involving greater than six clock hours of 
the retina (67%) and 8 patients had a choroidal detachment involving greater than six 
clock hours of the choroid (44%). Thirteen patients had between 1-2 past ocular surgeries 
(72%) and 4 patients had greater than two operations (22%). Nine patients had received 
prior retinal detachment surgery (50%) and 10 patients (56%) had received prior laser 
treatment (PRP, barrier, focal, etc.). 
Table 4: Detachment and Past Surgical Characteristics depicts factors pertaining to 
past surgeries and the primary retinal detachment with secondary choroidal detachment. 
All data represented as integers with percent sample in parentheses. All eyes n=18. 
Detachment and Past Surgical Characteristics 
  All Eyes (n=18) 
Status of Macula   
Macula off 8 (44%) 
Macula on 10 (56%) 
Retinal Detachment Clock Hours   
<6 Clock Hours 3 (17%) 
>6 Clock Hours 12 (67%) 
Undetermined Clock Hours 3 (17%) 
Choroidal Detachment Clock Hours   
<6 Clock Hours 8 (44%) 
>6 Clock Hours 8(44%) 
Undetermined Clock Hours 2 (11%) 
Previous Ocular Surgeries   
None 1 (6%) 
1-2 13 (72%) 
>2 4 (22%) 
Previous Retinal Detachment Operations   
None 9 (50%) 
1 9 (50%) 
Previous Laser Surgeries   
None 8 (44%) 
1-2 10 (56%) 
Previous Pars Plana Vitrectomy   
None 9 (50%) 
1 9 (50%) 
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Intraoperative Factors 
 Intraoperative factors are listed in Table 5. All 18 patients received 23-gauge PPV 
with SO tamponade (n=18 eyes). Twelve patients included a relaxing retinotomy (67%). 
Ten patients had direct drainage of their SCD (56%). Nine total patients had an epiretinal 
membrane peeling (ERM peel) (50%). Three patients had clinically significant ciliary 
body membranes, which were peeled endoscopically (17%). A total of ten patients had a 
complete vitrectomy under endoscopic assistance (56%). Two patients had their cataract 
removed in a lensectomy (11%) while one patient had a cataract removed and a PCIOL 
inserted (6%). 
Table 5: Postoperative Characteristics. Relates the use of different procedures during 
surgical intervention. A combination of procedures was implemented for each patient. 
Values shown as integers with percent populatuon in parentheses. All eyes n=18 
Postoperative Characteristics 
  All Eyes (n=18) 
Silicone Oil Tamponade 18 (100%) 
Operative Procedures   
Scleral Buckle 2 (11%) 
Retinotomy 12 (67%) 
Choroidal Drainage 10 (56%) 
Membrane Peel 9 (50%) 
Ciliary Body Peel 3 (17%) 
Endoscopy 10 (56%) 
Pars Plana Lensectomy 2 (11%) 
Phacoemulsification 1 (6%) 
 
Outcome Variables 
Outcome variables are displayed in Table 6. The follow-up time (displayed in 
months) ranged from 3-76 with a mean of 21.6. Primary anatomic success, defined as 
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reattachment of the retina to the underlying choroid, was achieved in eight cases (44%) 
with final anatomic success in 17 cases (94%). Nine patients (50%) had at least one 
follow-up retinal detachment surgery (50%), while zero patients required follow-up 
choroidal detachment surgery. Four cases had postoperative hypotony (22%), while 
postoperative ocular hypertension was seen in two cases (11%). One patient was 
diagnosed with glaucoma postoperatively and one patient developed phthisis bulbi 
postoperatively. Final BCVA had a mean of 1.85 (logMAR). The change in BCVA 
measured preoperatively to most recent follow-up ranged from -0.86-1.6 with a mean 
change of 0.06 (logMAR). The average duration of silicone oil tamponade was 5.55 
months. 
  
 33 
Table 6: Outcome Variables. Depicts the chosen outcome variables and their values for 
patients postoperatively. Values are integers where (mo) = months and all other values 
shown as integers with percent sample in parentheses. Anatomic success was determined 
by reattachment of the retina to the underlying choroid. All eyes n=18. 
Outcome Variables 
  All Eyes (n=18) 
Follow-up (mo)   
Mean 21.6 
Median 10.5 
Range 3-76 
Primary Anatomic Success 8 (44%) 
Final Anatomic Success 17 (94%) 
Follow-up Retinal Detachment Surgeries   
1 6 (33%) 
>1 3 (17%) 
Complications   
Final Intraocular Pressure <5 4 (22%) 
Final Intraocular Pressure >21 2 (11%) 
Hemorrhagic Choroidal Detachment 2 (11%) 
Phthisis Bulbi 1 (6%) 
Final Best Corrected Visual Acuity (LogMAR)   
<1.5 4 (22%) 
1.5-2.0 8 (44%) 
>2.0 6 (33%) 
Final Change in BCVA (LogMAR)   
Mean 0.06 
Median 0 
Range -0.85-1.6 
Silicone Oil Removal   
Yes 12 (67%) 
No 6 (33%) 
Silicone Oil Duration (mo)   
Mean 5.55 
Median 5 
Range 1.5-10 
Statistical Analytics 
 Statistical analyses are displayed in Table 7 for predicting outcome variables. 
Multiple factors were tested for significant differences in primary anatomic success, final 
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visual acuity, and change in visual acuity. Fewer previous operations was seen to be 
significantly correlated with decreased change in BCVA. Intraoperative choroidal 
drainage was seen to be significantly correlated with increased change in BCVA. Finally, 
ERM peeling was correlated with significantly higher primary anatomic success.  
The control statistics are displayed at the bottom of Table 7. The complicated retinal 
detachment control group had better rates of primary anatomic success, final BCVA, and 
change in BCVA compared to the retinal detachment with choroidal detachment group. 
However, only the final BCVA was significantly correlated with improving in the 
complicated retinal detachment control group as compared to the treatment group. 
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Table 7: Predicting Primary Anatomic Success and Final Visual Acuity for Patients 
with Primary RD Complicated by Secondary CD. Shows the p-values calculated using 
between-groups t-test for bivariate analysis. Control group statistics included at the 
bottom. Values were considered significant when p <= 0.05 for a confidence interval of 
95%. Bold indicates significant values. 
Predicting Primary Anatomic Success and Final Visual Acuity 
  P value 
Number of previous operations   
Primary Anatomic Success 0.3724 
Final BCVA 0.0594 
BCVA Change 0.0393* 
Number of laser procedures   
Primary Anatomic Success 0.6848 
Final BCVA 0.9243 
BCVA Change 0.8143 
Follow-up months   
Primary Anatomic Success 0.1839 
Final BCVA 0.3362 
BCVA Change 0.7103 
Preoperative Hypotony   
Primary Anatomic Success 0.6212 
Final BCVA 0.8075 
BCVA Change 0.7602 
Choroidal Drainage   
Primary Anatomic Success 0.9201 
Final BCVA 0.1115 
BCVA Change 0.0232* 
Epiretinal Membrane Peel   
Primary Anatomic Success 0.0167* 
Final BCVA 0.7577 
BCVA Change 0.2541 
Retinal Detachment Control Group   
Primary Anatomic Success 0.3244 
Final BCVA 0.0182* 
BCVA Change 0.1581 
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DISCUSSION 
On Results 
 The outcomes of this study fell into expected ranges for patients with RDCD. 
Final anatomic success, defined as the successful reattachment of the retina to the 
underlying choroid, was seen in 17 patients (94%) (Table 4), compared to standard 
success rates of ~90% for vitrectomy from previous studies (Sharma et al., 1998). Six 
patients (33%) experienced improved vision while 7 patients (39%) suffered vision loss, 
which is comparable to similar studies where less than 50% of patients improved vision 
(Gottlieb, 1972). No patient improved past 20/60. Overall mean change in BCVA from 
preoperative visual acuity to most recent follow-up was 0.06 (Table 4). Primary anatomic 
success was low with 8 patients (44%) receiving immediate reattachment of the retina, 
however, final anatomic success was considered normal with 17 patients (94%) receiving 
inevitable retinal reattachment. The one patient without anatomic success was determined 
by the presence of phthisis bulbi in the operative eye (Table 4). Finally, the visual 
outcomes of patients in this study were not great, with 6 patients (33%) improving and 7 
patients (39%) decreasing visual acuity, however, this is similar to previous literature 
(Table 4). That no patient improved past 20/60 is also indicative of the devastating 
impact RDCD has on visual outcomes (Seelenfreund, 1974). 
RDCD is a complicated process with a poorly understood pathophysiology. 
However, an investigation of preoperative factors and outcome variables can lead to a 
better understanding of this disease pattern. One striking notion is that of the advanced 
age of the sample group. This is most notable with the high rate of pseudophakia (Table 
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3). The National Eye Institute lists age as the primary risk factor for development of 
cataracts (National Eye Institute, 2015). The substantial number of pseudophakic patients 
can be idiopathic or it could be a risk factor for the development of detachments. One 
such study published by the American Academy of Ophthalmology showed no 
significant correlation between detachment risk and prior cataract removal or 
phacoemulsification (Erie et al., 2006). Another interesting preoperative result was the 
high rate of type II diabetes mellitus (NIDDM). 44% of the sample was diagnosed 
diabetic prior to surgery (Table 3). This could be a stochastic finding given the advanced 
age of the sample. However, diabetic traction has been shown to be associated with 
vitreous hemorrhages and eventual retinal detachments (Khatib & Carvounis, 2016). 
Finally, preoperative hypotony has been reported as a risk factor of RDCD (Gu et al., 
2016). Our study found an incidence of 44% for preoperative hypotony (Table 3). Other 
studies have concluded that the serous exudate involved in RDCD has a profile of 
inflammatory markers and metabolites (Yu et al., 2015) (Wu et al., 2016). If 
inflammation creates a serous exudate behind the choroid, then preoperative hypotony 
could lead to a favorable pressure gradient for transudation out of the uvea and into the 
suprachoroidal space. This mechanism is known as choroidal effusion and is governed by 
Starling’s law (Stefánsson, 2007). It is important to note that hypertension and NIDDM 
could also account for fluid transudation in this way. 
Three factors were shown to be significantly correlated with altering the outcomes 
of patients presenting with RDCD (Table 7). Patients who had fewer previous ocular 
surgeries were seen to have significantly improved change in BCVA (Table 7). Also, 
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patients who received a choroidal drainage procedure were shown to have a significant 
correlation with increased LogMAR, indicating vision loss (Table 7). Choroidal drainage 
is commonly performed after trabeculotomy procedures for maintenance of glaucoma 
(WuDunn et al., 2005) (Parikh et al., 2007). One research team has described a successful 
way to drain choroidal fluid without surgical intervention (Rezende et al., 2012). The 
surgical nature of the three-port, PPV could have deleterious effects on the drainage 
procedure when confronted with chronic hypotony. Finally, patients who received ERM 
peel showed significantly improved primary anatomical success rates. ERM peeling has 
been shown to be beneficial in preventing recurrent detachments and eliminating PVR 
(Lee et al., 2017). Given the high rate of recurrence and PVR (Table 3), it would follow 
that peeling the glial cell scar tissue would result in improved outcomes for patients with 
RDCD. 
Confounding Variables 
 When considering potential confounders in this study, there are several variables 
that may have an impact on the outcome variables measured. The high rate of diabetes 
can be a confounding variable since diabetic retinopathy can severely affect visual acuity. 
This could be a source of confounding as it would alter the postoperative course of 
recovery and final visual acuity. Another primary source of confounding is the follow-up 
time. Patients with shortened follow up data and patients with lengthy follow up data are 
confounders. Very short follow-up periods may not give the full picture of proper 
surgical recovery and therefore proper outcomes. Patients with long follow-up periods are 
increasing their risk for further ocular abnormalities or additional procedures, which 
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could alter the truth in viewing outcomes for a specific event such as surgical intervention 
for RDCD. Finally, a huge source of confounding comes from the difficulty in 
controlling for specific variables. Preoperative characteristics range wildly, and 
intraoperative procedures were individually tailored for each patient. 
Conclusion 
 In this project there were several possible questions to answer. Although 
definitive answers are not possible (correlation does not equal causation), the overall 
study of RD complicated by CD has been progressed. Watching outcome variables alter 
depending on subgroupings of patients will be beneficial for future vitreoretinal surgeons 
considering treatment plans for their patients. Hammering down pathophysiology is 
important, future study should be focused on the etiology of hypotony as well as its 
treatment as a preoperative and postoperative complication. In addition, surgical 
methodologies improve over time and this study shows that certain methodologies may 
be more beneficial than others for RDCD patients. In conclusion, RDCD is still seen as a 
devastating diagnosis for visual outcome, however, there is still hope in maintaining 
workable vision. Continued research with a longitudinal cohort using controlled surgical 
methods could be useful in evaluating more specifics for improving outcomes for these 
patients. 
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